After nebulization, LNPs loading mRNA encoding the nuclear receptor subfamily 1 group D member 1 (NR1D1), a circadian regulatory gene, markedly improve efficiency in treating bronchopulmonary dysplasia (BPD) in rats and pulmonary fibrosis in mice. The gene discussed is NR1D1; the disease is bronchopulmonary dysplasia.